Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review.
Opinion Statement: Inflammatory bowel diseases (IBD) are a group of chronic inflammatory gastrointestinal (GI) disorders, mainly represented by Crohn's disease and ulcerative colitis. Although the etiology of IBD is not fully understood, there is substantial evidence that immunologic, genetic, and e...
| Publicado en: | Current Treatment Options in Oncology Vol. 15; no. 3; pp. 405 - 421 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research systematic review Journal Article |
| Publicado: |
Springer Nature
Sep2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103843339&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 103843339 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15272729 3KHC jtl: Current Treatment Options in Oncology issn: 15272729 maglogo: N pubinfo: dt: Sep2014 vid: 15 iid: 3 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 103843339 97679921 NLM24792017 2012706002 10.1007/s11864-014-0288-2 NLM24792017 PMC4147240 103843339 ppf: 405 ppct: 16 formats: fmt: @attributes: type: P tig: atl: Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review. aug: au: Salaga, Maciej Zatorski, Hubert Sobczak, Marta Chen, Chunqiu Fichna, Jakub Sałaga, Maciej affil: Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland sug: subj: Colorectal Neoplasms Drug Therapy Drugs, Chinese Herbal Therapeutic Use Inflammatory Bowel Diseases Drug Therapy Medicine, Chinese Traditional Animals Clinical Trials Drug Evaluation, Preclinical Human Meta Analysis Models, Biological Professional Practice, Evidence-Based Systematic Review ab: Opinion Statement: Inflammatory bowel diseases (IBD) are a group of chronic inflammatory gastrointestinal (GI) disorders, mainly represented by Crohn's disease and ulcerative colitis. Although the etiology of IBD is not fully understood, there is substantial evidence that immunologic, genetic, and environmental factors are the main contributors in IBD pathogenesis. Conventional therapies for IBD include anti-inflammatory and immunosuppressive drugs, such as 5-aminosalicylic acid, corticosteroids, antibiotics, and biologicals, such as anti-TNFα antibodies. However, because of low efficacy and high risk of side effects, there is a clear need for the development of novel and efficient pharmacologic strategies in IBD treatment. Among various complementary and alternative medicine (CAM) approaches, which are used for the treatment of gastrointestinal (GI) disorders, traditional Chinese medicine (TCM) is one of the most developed and diversified. TCM encompasses methods and therapies that emerged over centuries and is based mostly on ethnic wisdom and observations transmitted from generation to generation. In the recent years, the efficacy of TCM as treatment of IBD has been extensively characterized in preclinical and clinical studies, which resulted in a significant number of research reports. Moreover, the popularity of TCM among patients with IBD has rapidly increased not only in Asia, but also in the Western hemisphere. pubtype: Academic Journal doctype: meta analysis research systematic review Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|